Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC
Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC
Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC
Submitted by
admin
on June 2, 2014 - 6:10pm
Source:
The Fly on the Wall
News Tags:
Novartis
Zykadia
non-small cell lung cancer
Headline:
Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC
Do Not Allow Advertisers to Use My Personal information
